These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 10739701
1. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation. Annab LA, Terry L, Cable PL, Brady J, Stampfer MR, Barrett JC, Afshari CA. Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701 [Abstract] [Full Text] [Related]
2. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF. Cancer Res; 1998 Aug 01; 58(15):3237-42. PubMed ID: 9699648 [Abstract] [Full Text] [Related]
3. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation. Huper G, Marks JR. Cancer Res; 2007 Apr 01; 67(7):2990-3001. PubMed ID: 17409405 [Abstract] [Full Text] [Related]
4. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P. Hum Mutat; 2005 Mar 01; 25(3):319. PubMed ID: 15712267 [Abstract] [Full Text] [Related]
5. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cavalli LR, Singh B, Isaacs C, Dickson RB, Haddad BR. Cancer Genet Cytogenet; 2004 Feb 01; 149(1):38-43. PubMed ID: 15104281 [Abstract] [Full Text] [Related]
6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX, Ried T. Oncogene; 2002 Aug 01; 21(33):5097-107. PubMed ID: 12140760 [Abstract] [Full Text] [Related]
7. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR. Cell Growth Differ; 1996 Jun 01; 7(6):711-5. PubMed ID: 8780884 [Abstract] [Full Text] [Related]
8. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status. Fishman A, Dekel E, Chetrit A, Lerner-Geva L, Bar-Am A, Beck D, Beller U, Ben-Baruch G, Piura B, Friedman E, Struewing JP, Modan B. Gynecol Oncol; 2000 Oct 01; 79(1):74-8. PubMed ID: 11006035 [Abstract] [Full Text] [Related]
9. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. Cancer Res; 2006 Jan 01; 66(1):41-5. PubMed ID: 16397213 [Abstract] [Full Text] [Related]
10. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID, Rosen EM. Oncogene; 2001 Dec 13; 20(57):8215-35. PubMed ID: 11781837 [Abstract] [Full Text] [Related]
11. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Bell DW, Erban J, Sgroi DC, Haber DA. Cancer Res; 2002 May 15; 62(10):2741-3. PubMed ID: 12019146 [Abstract] [Full Text] [Related]
12. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol. Bennett LM, McAllister KA, Malphurs J, Ward T, Collins NK, Seely JC, Gowen LC, Koller BH, Davis BJ, Wiseman RW. Cancer Res; 2000 Jul 01; 60(13):3461-9. PubMed ID: 10910057 [Abstract] [Full Text] [Related]
13. Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S, Klein C, Sitarik M, Deffenbaugh AM, Graw SL. Cancer; 2003 Aug 01; 98(3):597-602. PubMed ID: 12879478 [Abstract] [Full Text] [Related]
14. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes. Campbell M, Aprelikova ON, van der Meer R, Woltjer RL, Yee CJ, Liu ET, Jensen RA. Cancer Gene Ther; 2001 Mar 01; 8(3):231-9. PubMed ID: 11332994 [Abstract] [Full Text] [Related]
15. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer. Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE. Gynecol Oncol; 2001 Nov 01; 83(2):383-7. PubMed ID: 11606101 [Abstract] [Full Text] [Related]
16. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ, Cowan KH. Cell Growth Differ; 1996 Jun 01; 7(6):717-23. PubMed ID: 8780885 [Abstract] [Full Text] [Related]
17. [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers]. Feunteun J. J Soc Biol; 2004 Jun 01; 198(2):123-6. PubMed ID: 15368961 [Abstract] [Full Text] [Related]
18. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX. Nat Genet; 2001 Jul 01; 28(3):266-71. PubMed ID: 11431698 [Abstract] [Full Text] [Related]
19. [Frequency of the 185delAG mutation in the BRCA1 gene in Chilean healthy women with family history of breast cancer]. Jara L, Ampuero S, Seccia L, Bustamante M, Blanco R, Santibáñez E, Reyes JM, Ojeda JM. Rev Med Chil; 2002 Oct 01; 130(10):1113-23. PubMed ID: 12491828 [Abstract] [Full Text] [Related]
20. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI. Cancer Res; 2002 Mar 01; 62(5):1481-8. PubMed ID: 11888924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]